Clinical applicability and cost of a 46-gene panel for genomic analysis of solid tumours: Retrospective validation and prospective audit in the UK National Health Service | PLOS Medicine
![A comprehensive custom panel design for routine hereditary cancer testing: preserving control, improving diagnostics and revealing a complex variation landscape | Scientific Reports A comprehensive custom panel design for routine hereditary cancer testing: preserving control, improving diagnostics and revealing a complex variation landscape | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fsrep39348/MediaObjects/41598_2017_Article_BFsrep39348_Fig1_HTML.jpg)
A comprehensive custom panel design for routine hereditary cancer testing: preserving control, improving diagnostics and revealing a complex variation landscape | Scientific Reports
![A multi-gene panel beyond BRCA1/BRCA2 to identify new breast cancer-predisposing mutations by a picodroplet PCR followed by a next-generation sequencing strategy: a pilot study - ScienceDirect A multi-gene panel beyond BRCA1/BRCA2 to identify new breast cancer-predisposing mutations by a picodroplet PCR followed by a next-generation sequencing strategy: a pilot study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0003267018311036-fx1.jpg)
A multi-gene panel beyond BRCA1/BRCA2 to identify new breast cancer-predisposing mutations by a picodroplet PCR followed by a next-generation sequencing strategy: a pilot study - ScienceDirect
![Fragmentation patterns and personalized sequencing of cell‐free DNA in urine and plasma of glioma patients | EMBO Molecular Medicine Fragmentation patterns and personalized sequencing of cell‐free DNA in urine and plasma of glioma patients | EMBO Molecular Medicine](https://www.embopress.org/cms/asset/08993d8f-006c-4b1e-ae77-567602bf019a/emmm202012881-abs-0001-m.jpg)
Fragmentation patterns and personalized sequencing of cell‐free DNA in urine and plasma of glioma patients | EMBO Molecular Medicine
![Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group - ScienceDirect Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0923753420399713-gr1.jpg)
Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group - ScienceDirect
![Frontiers | Validation and Clinical Applications of a Comprehensive Next Generation Sequencing System for Molecular Characterization of Solid Cancer Tissues Frontiers | Validation and Clinical Applications of a Comprehensive Next Generation Sequencing System for Molecular Characterization of Solid Cancer Tissues](https://www.frontiersin.org/files/Articles/470457/fmolb-06-00082-HTML/image_m/fmolb-06-00082-g001.jpg)
Frontiers | Validation and Clinical Applications of a Comprehensive Next Generation Sequencing System for Molecular Characterization of Solid Cancer Tissues
![Implementation of a prostate cancer‐specific targeted sequencing panel for credentialing of patient‐derived cell lines and genomic characterization of patient samples - Stover - 2022 - The Prostate - Wiley Online Library Implementation of a prostate cancer‐specific targeted sequencing panel for credentialing of patient‐derived cell lines and genomic characterization of patient samples - Stover - 2022 - The Prostate - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/687be78a-2df8-4e70-918f-0c101393d24b/pros24305-fig-0001-m.jpg)
Implementation of a prostate cancer‐specific targeted sequencing panel for credentialing of patient‐derived cell lines and genomic characterization of patient samples - Stover - 2022 - The Prostate - Wiley Online Library
![Cross-oncopanel study reveals high sensitivity and accuracy with overall analytical performance depending on genomic regions | Genome Biology | Full Text Cross-oncopanel study reveals high sensitivity and accuracy with overall analytical performance depending on genomic regions | Genome Biology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13059-021-02315-0/MediaObjects/13059_2021_2315_Fig1_HTML.png)
Cross-oncopanel study reveals high sensitivity and accuracy with overall analytical performance depending on genomic regions | Genome Biology | Full Text
Identification of Variants in Primary and Recurrent Glioblastoma Using a Cancer-Specific Gene Panel and Whole Exome Sequencing | PLOS ONE
![Economic Impact of Next-Generation Sequencing Versus Single-Gene Testing to Detect Genomic Alterations in Metastatic Non–Small-Cell Lung Cancer Using a Decision Analytic Model | JCO Precision Oncology Economic Impact of Next-Generation Sequencing Versus Single-Gene Testing to Detect Genomic Alterations in Metastatic Non–Small-Cell Lung Cancer Using a Decision Analytic Model | JCO Precision Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/po/2019/po.2019.3/po.18.00356/20190515/images/large/po.18.00356t4.jpeg)
Economic Impact of Next-Generation Sequencing Versus Single-Gene Testing to Detect Genomic Alterations in Metastatic Non–Small-Cell Lung Cancer Using a Decision Analytic Model | JCO Precision Oncology
![Clinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome and transcriptome | Nature Communications Clinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome and transcriptome | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-018-06485-7/MediaObjects/41467_2018_6485_Fig1_HTML.png)
Clinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome and transcriptome | Nature Communications
![Frontiers | Analysis of Sequence and Copy Number Variants in Canadian Patient Cohort With Familial Cancer Syndromes Using a Unique Next Generation Sequencing Based Approach Frontiers | Analysis of Sequence and Copy Number Variants in Canadian Patient Cohort With Familial Cancer Syndromes Using a Unique Next Generation Sequencing Based Approach](https://www.frontiersin.org/files/Articles/698595/fgene-12-698595-HTML/image_m/fgene-12-698595-g001.jpg)
Frontiers | Analysis of Sequence and Copy Number Variants in Canadian Patient Cohort With Familial Cancer Syndromes Using a Unique Next Generation Sequencing Based Approach
![Life | Free Full-Text | From Samples to Germline and Somatic Sequence Variation: A Focus on Next-Generation Sequencing in Melanoma Research Life | Free Full-Text | From Samples to Germline and Somatic Sequence Variation: A Focus on Next-Generation Sequencing in Melanoma Research](https://pub.mdpi-res.com/life/life-12-01939/article_deploy/html/images/life-12-01939-g001.png?1669030154)
Life | Free Full-Text | From Samples to Germline and Somatic Sequence Variation: A Focus on Next-Generation Sequencing in Melanoma Research
![Comprehensive assay for the molecular profiling of cancer by target enrichment from formalin‐fixed paraffin‐embedded specimens - Kohsaka - 2019 - Cancer Science - Wiley Online Library Comprehensive assay for the molecular profiling of cancer by target enrichment from formalin‐fixed paraffin‐embedded specimens - Kohsaka - 2019 - Cancer Science - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/37971833-47f9-4d6b-89c2-d7c6775bef21/cas13968-fig-0004-m.jpg)
Comprehensive assay for the molecular profiling of cancer by target enrichment from formalin‐fixed paraffin‐embedded specimens - Kohsaka - 2019 - Cancer Science - Wiley Online Library
![AmpliSeq™ for Illumina Oncology Panels on the iSeq™ 100 System - Illumina, Inc. - PDF Catalogs | Technical Documentation AmpliSeq™ for Illumina Oncology Panels on the iSeq™ 100 System - Illumina, Inc. - PDF Catalogs | Technical Documentation](https://img.medicalexpo.com/pdf/repository_me/83632/ampliseq-illumina-oncology-panels-iseq-100-system-192086_1mg.jpg)
AmpliSeq™ for Illumina Oncology Panels on the iSeq™ 100 System - Illumina, Inc. - PDF Catalogs | Technical Documentation
Tumor heterogeneity measurement from cancer panel sequencing. (a) Tumor... | Download Scientific Diagram
![JMP | Free Full-Text | Analysis of Copy Number Variations in Solid Tumors Using a Next Generation Sequencing Custom Panel JMP | Free Full-Text | Analysis of Copy Number Variations in Solid Tumors Using a Next Generation Sequencing Custom Panel](https://pub.mdpi-res.com/jmp/jmp-02-00013/article_deploy/html/images/jmp-02-00013-g001.png?1621662645)